A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2002
10/09/2002	EP1246935A2 Highly conserved genes and their use to generate probes and primers for detection of microorganisms
10/09/2002	EP1246932A1 Conjugated fatty acids and related compounds, and method for their enzymatic preparation
10/09/2002	EP1246931A1 Compositions comprising nucleic acids incorporated in bilaminar mineral particles
10/09/2002	EP1246917A2 Human stra6 polypeptides
10/09/2002	EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002	EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002	EP1246843A1 Novel fgf homolog zfgf12
10/09/2002	EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002	EP1246841A1 Transcription factors containing two potential dna binding motifs
10/09/2002	EP1246835A2 Substituted sapogenins and their use
10/09/2002	EP1246829A1 Novel heterocycles
10/09/2002	EP1246828A1 Benzosulfones with calcium antagonist activity
10/09/2002	EP1246827A1 New polymorphic forms of olanzapine
10/09/2002	EP1246826A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them
10/09/2002	EP1246825A1 Fused pyrrole compounds, pharmaceutical agents containing the same, and the use thereof
10/09/2002	EP1246824A1 Carboxamide diazepin derivatives, preparation method, use as medicines, pharmaceutical compositions and use thereof
10/09/2002	EP1246823A1 Pyrimidine and triazine kinase inhibitors
10/09/2002	EP1246821A2 Process for the preparation of paroxetine and synthetic intermeditates thereof
10/09/2002	EP1246820A1 Novel heteroaryl derivatives, their preparation and use
10/09/2002	EP1246818A1 Novel indole derivatives
10/09/2002	EP1246817A1 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
10/09/2002	EP1246816A1 Substituted phenyl-piperazine derivatives, their preparation and use
10/09/2002	EP1246815A1 Phenylpiperazinyl derivatives
10/09/2002	EP1246810A1 Piperidinyloxy and pyrrolidinyloxyphenyl oxazolidinones as antibacterials
10/09/2002	EP1246809A1 5-aryl-1h-1,2,4-triazole compounds as inhibitors of cyclooxygenase-2 and pharmaceutical compositions containing them
10/09/2002	EP1246808A1 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation
10/09/2002	EP1246807A2 Novel hydantoin, thiohydantoin, pyrimidinedione and thioxopyrimidinone derivatives, preparation method and use as medicines
10/09/2002	EP1246806A1 Arly- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002	EP1246805A1 4-phenyl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
10/09/2002	EP1246804A1 4-carboxyamino-2-ethyl-1,2,3,4-tetrahydroquinoline crystal as cetp inhibitor
10/09/2002	EP1246803A1 Piperidine and piperazine derivatives which function as 5-ht 2a? receptor antagonists
10/09/2002	EP1246800A1 Beta-amino acid compounds as integrin antagonists
10/09/2002	EP1246799A1 Substituted pyrrole mannich bases to combat pain and allergic reactions
10/09/2002	EP1246795A2 Antibacterial agents
10/09/2002	EP1246793A2 Substituted aminomethyl-phenyl-cyclohexane derivatives
10/09/2002	EP1246792A1 Compounds and compositions for delivering active agents
10/09/2002	EP1246791A2 Aminomethyl-phenyl-cyclohexanone derivatives
10/09/2002	EP1246790A1 Substituted 1 and 2 naphthol mannich bases
10/09/2002	EP1246789A1 Racemic and optically pure metabolites of sibutramine, their preparation, compositions comprising them and their use as dopamine reuptake inhibitors
10/09/2002	EP1246668A1 An rapid acting freeze dired oral pharmaceutical composition for treating migraine
10/09/2002	EP1246648A2 Dendrimer-photosensitizer complexes for medical applications
10/09/2002	EP1246646A2 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen
10/09/2002	EP1246642A2 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization
10/09/2002	EP1246641A2 The parenteral use of bacterial phage associated lysing enzymes for the therapeutic treatment of bacterial infections
10/09/2002	EP1246640A2 Method and composition for treatment and/or prevention of antibiotic-resistant microorganism infections
10/09/2002	EP1246638A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
10/09/2002	EP1246632A1 Catechins and green tea extract for the treatment of amyloidosis in alzheimer's disease and other amyloidoses
10/09/2002	EP1246631A1 Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures
10/09/2002	EP1246628A1 Physiologically balanced, ionized, acidic solution and methodology for use in wound healing
10/09/2002	EP1246627A2 Polyanhydrides with biologically active degradation products
10/09/2002	EP1246626A1 Use of a cyclic ether for the preparation of medicaments affecting glucose tolerance
10/09/2002	EP1246625A2 Methods and compositions for mitigating pain using nitrate esters
10/09/2002	EP1246624A2 Triazinone compounds for treating diseases resulting from infestation with parasitic protozoans
10/09/2002	EP1246623A1 Compounds specific to adenosine a1, a2a, and a3 receptor and uses thereof
10/09/2002	EP1246622A1 Novel substituted benzimidazole dosage forms and method of using same
10/09/2002	EP1246621A1 Nitrosated and nitrosylated cyclooxygenase-2 inhibitors, compositions and methods of use
10/09/2002	EP1246620A1 Substituted acylhydroxamic acids and method of reducing tnf-g(a) levels
10/09/2002	EP1246619A1 Urotensin-ii receptor antagonists
10/09/2002	EP1246618A1 N,n'-bis(2-hydroxybenzyl)ethylenediamine-n,n'-diacetic acid in iron chelating therapy
10/09/2002	EP1246617A2 Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of tumors of the central nervous system
10/09/2002	EP1246616A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use
10/09/2002	EP1246614A1 Osmotic device containing venlafaxine and an anti-psychotic agent
10/09/2002	EP1246612A1 Osmotic device containing pseudoephedrine and an h1 antagonist
10/09/2002	EP1246611A2 Formulations of active components in the form of a solid dispersion
10/09/2002	EP1246608A1 Pharmaceutical formulations for the delivery of drugs having low aqueous solubility
10/09/2002	EP1246605A2 Facilitating the preservation of sight by increasing optic nerve, choroidal and retinal blood flow
10/09/2002	EP1246604A1 Use of orally administered dehydroepiandrosterone, precursors and derivatives thereof in order to improve the papery aspect of the skin
10/09/2002	EP1246603A1 Oral use of dehydroepiandrosterone and some of its derivatives as pigmentation regulators
10/09/2002	EP1246601A1 Antiperspirant compositions
10/09/2002	EP1246590A1 Local prevention or amelioration of pain from surgically closed wounds
10/09/2002	EP1246538A1 Thickened oil compositions of edible oil
10/09/2002	EP1133495B1 Semi-hydrochloride of 8-cyan-1- cyclopropyl -7-(1s,6s-2 ,8-diazabicyclo 4.3.0]nonan -8-yl)-6- fluoro-1, 4-dihydro -4-oxo-3- quinoline carboxylic acid
10/09/2002	EP1129208B1 Vancoresmycin, a process for its production and its use as a pharmaceutical
10/09/2002	EP1115391B1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin
10/09/2002	EP1098931B1 Polyionic hydrogels based on xanthan and chitosan for stabilising and controlled release of vitamins
10/09/2002	EP1077681B1 Pharmaceutical preparation containing levothyroxine sodium
10/09/2002	EP1066029B1 Peroral active agent suspension
10/09/2002	EP1049467B1 Celecoxib compositions
10/09/2002	EP1039909B1 Method of production and composition of an oral preparation of itraconazole
10/09/2002	EP1037874B1 1-(adamantyl)amidines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission
10/09/2002	EP1035826B1 Hair and/or body hygienic product for human beings and animals
10/09/2002	EP1024798B1 Neomycin/disaccharide water solution for enteroclysis in hepatic encephalopathy
10/09/2002	EP1009411A4 Method and composition for treating sleep apnea
10/09/2002	EP0996622B1 Novel spiroazabicyclic heterocyclic compounds
10/09/2002	EP0981967B1 Feed composition for broilers and method for breeding broilers
10/09/2002	EP0973550B1 Antagonistic anti-avb3 integrin antibodies
10/09/2002	EP0971714B1 Method of using cyclooxygenase-2 inhibitors in the treatment and prevention of dementia
10/09/2002	EP0964856B1 Bicyclic amino acids
10/09/2002	EP0946542B1 Indane or dihydroindole derivatives
10/09/2002	EP0944613B1 Benzopyran derivatives
10/09/2002	EP0931088B1 Novel erythromycin derivatives, method for preparing same and use thereof as drugs
10/09/2002	EP0910381A4 Method for treating pain
10/09/2002	EP0904061B1 Pharmaceutical composition with base of rhein or diacerhein with improved biological availability
10/09/2002	EP0897301B1 Method of treating otitis media with uridine triphosphates and related compounds
10/09/2002	EP0892634B1 Use of octoxyglycerin in a cosmetic and/or dermatological composition as active agent for the treatment of seborrhoea and/or acne
10/09/2002	EP0880360B1 Novel methods of vaccination and vaccines therefore comprising a nucleic acid encoding a first epitope and a peptide containing a second epitope
10/09/2002	EP0868434B1 Anti-idiotypic antibodies of vascular endothelial growth factor and use thereof as drugs
10/09/2002	EP0853477B1 At1-receptor antagonists for preventing and treating postischemic renal failure and for protecting ischemic kidneys
10/09/2002	EP0837686B1 Use of indigestible oligosaccharides to treat and prevent otitis media in humans
10/09/2002	EP0827505B1 Selected soluble esters of hydroxyl-containing indolocarbazoles

1 ... 5686 5687 5688 5689 5690 5691 5692 5693 5694 5695 5696 5697 5698 5699 5700 5701 5702 5703 5704 5705 5706 ... 7860